Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Biomarker Utilisation & Commercialisation

10 Sep 2014 - 11 Sep 2014 - London, UK



Bookmark and Share


The ACI Biomarker Utilisation & Commercialisation conference will take place on the 10th & 11th September in London. The event will explore the value of biomarkers from both a clinical and commercial perspective.

The aim of the event is to help end-users to develop a comprehensive strategy for biomarker discovery, development, application and analysis in clinical trials.
Attendees will get to meet renowned experts in biomarkers to discuss and debate key issues. All this takes place in a friendly environment designed to encourage networking between participants.

Topics on the agenda:
Benefit from an instructive two-day programme that explores a range of clinical and commercial factors affecting decision-makers in the world of biomarkers, combined with the opportunity for interaction with key opinion leaders.

Presentation Topics Include:
* Creating and Capturing Value with Biomarkers.
* Innovative Commercialisation of Companion Diagnostic Solutions 
* The Use of Human Genetics to Identify Novel Biomarkers for Clinical Trials
* Biomarker Discovery to Diagnostic Development: What are the Challenges? 
* Applying Imaging Biomarkers to Reduce Risk in Drug Development 
* Intellectual Property Protection for Biomarker Utilisation 
* Biomarkers in Personalised Medicine: From Discovery to Repositioning 
* Statistical Innovations in Biomarker Utilisation

Confirmed speaker companies include:
* Teva * Pfizer * Bayer Schering Pharma * Roche Diagnostics * Actelion * Comprehensive Biomarker Center GmbH * TNO * Biogerontology Research Foundation * Eisai * Westminster Genomic Services * Harrison Goddard Foote LLP * Cambridge Consultants * University College Dublin * Lloyd’s Register Quality Assurance (LRQA) * Medimmune * University College Dublin * Imanova *

For a copy of the conference programme or to register your attendance contact Cheryl Williams on +44 (0) 203 141 0623 or email cwilliams@acieu.net


Further information
Scientific News
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!